Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT - Get Free Report) shares traded up 17.1% on Monday . The stock traded as high as $10.91 and last traded at $10.91. 169,438 shares traded hands during trading, a decline of 45% from the average session volume of 310,313 shares. The stock had previously closed at $9.32.
Analysts Set New Price Targets
Separately, Wall Street Zen raised shares of Zhengye Biotechnology to a "hold" rating in a research note on Saturday, August 2nd.
Read Our Latest Report on Zhengye Biotechnology
Zhengye Biotechnology Stock Down 2.5%
The company has a debt-to-equity ratio of 0.01, a current ratio of 1.31 and a quick ratio of 0.88. The firm's 50-day moving average is $7.48 and its 200 day moving average is $7.24.
Hedge Funds Weigh In On Zhengye Biotechnology
A number of large investors have recently made changes to their positions in the stock. Jane Street Group LLC purchased a new position in shares of Zhengye Biotechnology in the 2nd quarter valued at about $1,158,000. Invesco Ltd. acquired a new stake in Zhengye Biotechnology in the 2nd quarter valued at about $220,000. Finally, Geode Capital Management LLC acquired a new stake in Zhengye Biotechnology in the 2nd quarter valued at about $174,000.
Zhengye Biotechnology Company Profile
(
Get Free Report)
Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.
Read More
Before you consider Zhengye Biotechnology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zhengye Biotechnology wasn't on the list.
While Zhengye Biotechnology currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
